News
- Quintiles Transnational to Buy Eidetics
- UNC Picks Thorp to Be Chancellor
- BDSI's Pain Patch Does Well in Human Trial
- Biotechnology Center Taps Chris Brodie to Lead Communications
- SEBIO Announces Semi-Finalists for Competition
- ConvaTec Sold to New Owners for $4.1 billion
- Duke, FDA Experts Lead Clinical Trials Group
- ParagonDx Gets FDA OK For Warafin Test
- Targacept Decision Triggers Milestone Payment
- Cornerstone Acquiring Critical Therapeutics

